Left Atrial Appendage Occlusion With WATCHMAN® Device in Patients With Non-valvular Atrial Fibrillation and End-stage Chronic Kidney Disease on Hemodialysis

CompletedOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

March 14, 2018

Primary Completion Date

January 7, 2022

Study Completion Date

January 7, 2022

Conditions
Atrial FibrillationHeart DiseasesRenal DiseaseBleedingArrhythmias, CardiacCardiovascular Diseases
Interventions
OTHER

Non Intervention

To assess the procedural safety and efficacy on stroke and bleeding prevention of LAAC in patients with NVAF and ESCKD on HD

Trial Locations (20)

11009

Hospital Universitario Puerta del Mar, Cadiz

15706

Hospital Clínico Universitario Santiago de Compostela, Santiago de Compostela

21005

Hospital Juan Ramón Jiménez Huelva, Huelva

23007

Complejo Hospitalario de Jaén, Jaén

24071

Hospital Universitario de León, León

28040

Hospital Clínico Universitario San Carlos, Madrid

28222

Hospital Universitario Puerta de Hierro, Madrid

28922

Hospital Universitario Fundación Alcorcón, Alcorcón

29603

Hospital Costa del Sol, Marbella

30120

Hospital Universitario Virgen de Arrixaca, Murcia

31008

Clínica Universitaria de Navarra, Pamplona

33011

Hospital Universitario Central de Asturias, Oviedo

35010

Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria

37007

Hospital Clínico Universitario de Salamanca, Salamanca

41009

Hospital Universitario Virgen de la Macarena, Seville

50009

Hospital Universitario Miguel Servet, Zaragoza

03293

Hospital de Vinalopó, Torrevieja

03010

Hospital General Universitario de Alicante, Alicante

08036

Hospital Clinic de Barcelona, Barcelona

08041

Hospital Santa Creu y Sant Pau, Barcelona

All Listed Sponsors
lead

Fundación EPIC

OTHER

NCT03446794 - Left Atrial Appendage Occlusion With WATCHMAN® Device in Patients With Non-valvular Atrial Fibrillation and End-stage Chronic Kidney Disease on Hemodialysis | Biotech Hunter | Biotech Hunter